Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. PAVmed Inc.
  6. Financials
    PAVM   US70387R1068

PAVMED INC.

(PAVM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 26,145,7136148148-
Enterprise Value (EV)1 26,145,713698,798,7148
P/E ratio -1,15x-2,18x-2,90x-2,87x-2,95x-3,11x
Yield ------
Capitalization / Revenue ---216x18,2x7,09x
EV / Revenue ---144x12,1x7,09x
EV / EBITDA ---5,83x-2,18x-2,07x-
Price to Book ---212x1,81x3,29x-
Nbr of stocks (in thousands) 27 14338 11464 14187 93587 935-
Reference price (USD) 0,961,202,121,681,681,68
Announcement Date 04/01/201904/09/202003/15/2021---
1 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 ---0,688,1320,8
EBITDA1 ---23,3-45,4-47,6-
Operating profit (EBIT)1 -10,6-14,3-23,4-48,7-50,2-40,2
Operating Margin ----7 134%-617%-193%
Pre-Tax Profit (EBT)1 -18,2-17,3-35,9-50,7-55,5-48,9
Net income1 -18,8-16,7-34,6-47,3-49,9-48,0
Net margin ----6 918%-614%-230%
EPS2 -0,84-0,55-0,73-0,59-0,57-0,54
Dividend per Share ------
Announcement Date 04/01/201904/09/202003/15/2021---
1 USD in Million
2 USD
Previous periodNext period
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 --0,200,480,671,30
EBITDA1 -9,42-11,5-12,2-12,3-12,3-12,1
Operating profit (EBIT)1 -9,43-11,5-13,7-14,0-14,2-14,1
Operating Margin ---6 834%-2 904%-2 134%-1 084%
Pre-Tax Profit (EBT)1 -10,1-12,7-13,7-14,0-14,2-14,1
Net income1 -9,51-11,5-12,3-13,9-14,2-14,0
Net margin ---6 147%-2 885%-2 123%-1 078%
EPS2 -0,13-0,14-0,15-0,16-0,16-0,16
Dividend per Share ------
Announcement Date 05/17/202108/12/202111/16/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 ---49,049,0-
Leverage (Debt / EBITDA) ---1,08x1,03x-
Free Cash Flow1 ----38,0-29,1-25,9
ROE (Net Profit / Equities) ------
Shareholders' equity1 ------
ROA (Net Profit / Asset) ------
Assets1 ------
Book Value Per Share2 ---0,010,930,51-
Cash Flow per Share ------
Capex1 --0,060,230,511,00
Capex / Sales ---33,7%6,27%4,80%
Announcement Date 04/01/201904/09/202003/15/2021---
1 USD in Million
2 USD
Previous periodNext period
Key data
Capitalization (USD) 147 729 978
Number of employees 25
Free-Float 89,5%
Free-Float capitalization (USD) 132 245 801
Avg. Exchange 20 sessions (USD) 3 152 122
Average Daily Capital Traded 2,13%
EPS & Dividend